SURMODICS INC — Director's Dealing 2016

Aug 3, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2016-08-01

Reporting Person: OLSON CHARLES W (Senior VP & GM, Med Dev)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-01	Common Stock	M	12500	$24.30	Acquired	35531	Direct
2016-08-01	Common Stock	S	7500	$27.0881	Disposed	28031	Direct
2016-08-01	Common Stock	S	5000	$27.0732	Disposed	23031	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-01	Stock Option (right to buy)	$24.30	M	12500	Disposed	2016-09-21	Common Stock (12500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	800	Indirect

Footnotes

F1: Exercise of reporting person's stock options of which shares were sold to pay the exercise price, to cover withholding taxes, and to pay broker fees and commissions, pursuant to a broker-assisted cashless exercise and sale.

F2: Reflects the weighted average price of 7,500 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 1, 2016 with sale prices ranging from $26.99 to $27.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Reflects the weighted average price of 5,000 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 1, 2016 with sale prices ranging from $27.05 to $27.12 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: This option is fully vested.